Boehringer Ingelheim Finally Increases Presence

To read the full article, please choose one of the following options:

India is one the leading emerging markets for pharmaceutical companies. Sales of medicines are experiencing double digit growth each year, low labour costs makes it a premier manufacturing hub, and the vast treatment-naïve population makes it an attractive location for clinical trials. Accordingly, it would be safe to presuppose that every multinational drugmaker has a sizeable presence on the sub-continent? The answer is a surprising no and German firm Boehringer Ingelheim is one of them. BMI takes a look at the tactics being employed by the Rhineland-Palatinate company to penetrate the Indian